Cash Flow Statement
Growth Metrics

Bio Key International (BKYI) Return on Equity (2016 - 2025)

Bio Key International (BKYI) has disclosed Return on Equity for 15 consecutive years, with 0.66% as the latest value for Q3 2025.

  • Quarterly Return on Equity fell 1212.0% to 0.66% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 0.66% through Sep 2025, down 1212.0% year-over-year, with the annual reading at 1.78% for FY2024, 90.0% up from the prior year.
  • Return on Equity hit 0.66% in Q3 2025 for Bio Key International, down from 0.56% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 24.54% in Q2 2024 to a low of 34.07% in Q3 2023.
  • Historically, Return on Equity has averaged 2.79% across 5 years, with a median of 0.57% in 2022.
  • Biggest five-year swings in Return on Equity: crashed -3349bps in 2023 and later surged 4553bps in 2024.
  • Year by year, Return on Equity stood at 0.3% in 2021, then tumbled by -383bps to 1.44% in 2022, then plummeted by -1943bps to 29.49% in 2023, then surged by 93bps to 2.2% in 2024, then skyrocketed by 70bps to 0.66% in 2025.
  • Business Quant data shows Return on Equity for BKYI at 0.66% in Q3 2025, 0.56% in Q2 2025, and 0.8% in Q1 2025.